Alexandria Real Estate Equities

AgriMetis, LLC is engaged in the research, development, and production of crop protection products, specifically focusing on fungicides, herbicides, insecticides, and nematicides derived from natural sources. Founded in 2014, the company is headquartered in Lutherville, Maryland, with additional facilities in Research Triangle Park, North Carolina, and a laboratory in Gaithersburg, Maryland. AgriMetis aims to provide sustainable and effective solutions for protecting crops from weeds, fungal diseases, and insect pests, offering farmers safe and cost-effective options for crop management. Its innovative approach combines natural product-derived compounds with advanced production processes to address the challenges faced in agricultural protection.

MacroGenics, Inc. is a biopharmaceutical company based in Rockville, Maryland, that specializes in the discovery and development of antibody-based therapeutics for cancer treatment. The company's portfolio includes several investigational products, such as Margetuximab, a monoclonal antibody in Phase III trials targeting HER2-expressing tumors, and Flotetuzumab, a DART molecule aimed at treating acute myeloid leukemia. Other candidates in development include MGA012 and MGD013, both targeting PD-1, as well as MGD019, which targets multiple immune checkpoints. MacroGenics is also advancing MGC018, an antibody-drug conjugate targeting B7-H3, and MGD014, a DART molecule designed for HIV-infected cells. The company has formed strategic collaborations with several organizations to enhance its research and development efforts. Founded in 2000, MacroGenics is committed to innovating immunotherapeutics for cancer and other related diseases.